Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Energy Transfer Partners
ET
|
$1.18B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$1.08B |
| 3 |
Merck
MRK
|
$788M |
| 4 |
Starbucks
SBUX
|
$708M |
| 5 |
TSMC
TSM
|
$521M |
Top Sells
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$1.64B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$722M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$713M |
| 4 |
COL
Rockwell Collins
COL
|
$610M |
| 5 |
ANDV
Andeavor
ANDV
|
$570M |
Sector Composition
| 1 | Technology | 13.3% |
| 2 | Financials | 11.29% |
| 3 | Healthcare | 10.77% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Energy | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$140B
| $572M | 0.18% | 9,142,438 -606,828 | -6% | -$38M |
|
77
Salesforce
CRM
$245B
| $568M | 0.18% | 4,150,286 -757,588 | -15% | -$104M |
|
78
Alerian MLP ETF
AMLP
$10.7B
| $565M | 0.18% | 64,701,090 +14,928,748 | +30% | +$130M |
|
79
SPDR S&P Bank ETF
KBE
$1.63B
| $559M | 0.18% | 14,966,603 -403,314 | -3% | -$15.1M |
|
80
Biogen
BIIB
$19.4B
| $542M | 0.17% | 1,801,221 -462,032 | -20% | -$139M |
|
81
ConocoPhillips
COP
$124B
| $542M | 0.17% | 8,690,173 -964,308 | -10% | -$60.1M |
|
82
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $538M | 0.17% | 11,401,997 +957,884 | +9% | +$45.2M |
|
83
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $536M | 0.17% | 14,441,672 -1,542,241 | -10% | -$57.2M |
|
84
SPDR Bloomberg High Yield Bond ETF
JNK
$8.14B
| $516M | 0.16% | 15,371,903 +1,338,673 | +10% | +$45M |
|
85
Zoetis
ZTS
$69.3B
| $504M | 0.16% | 5,896,855 -204,211 | -3% | -$17.5M |
|
86
Simon Property Group
SPG
$59B
| $499M | 0.16% | 2,972,632 -507,497 | -15% | -$85.3M |
|
87
CVS Health
CVS
$92.8B
| $497M | 0.16% | 7,590,077 +2,274,790 | +43% | +$149M |
|
88
Philip Morris
PM
$260B
| $493M | 0.16% | 7,379,052 -1,947,903 | -21% | -$130M |
|
89
Boston Scientific
BSX
$156B
| $490M | 0.16% | 13,877,955 -1,854,595 | -12% | -$65.5M |
|
90
NVIDIA
NVDA
$4.24T
| $489M | 0.16% | 3,661,813 +234,358 | +7% | +$31.3M |
|
91
SPDR S&P Biotech ETF
XBI
$5.16B
| $481M | 0.15% | 6,703,130 -2,235,877 | -25% | -$160M |
|
92
Humana
HUM
$36.5B
| $475M | 0.15% | 1,656,602 +288,999 | +21% | +$82.8M |
|
93
Altria Group
MO
$113B
| $468M | 0.15% | 9,469,981 -1,263,286 | -12% | -$62.4M |
|
|
TFCF
94
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $467M | 0.15% | 9,783,788 +2,662,213 | +37% | +$127M |
|
95
Costco
COST
$418B
| $461M | 0.15% | 2,262,130 -397,268 | -15% | -$80.9M |
|
96
3M
MMM
$82.8B
| $460M | 0.15% | 2,412,260 -254,876 | -10% | -$48.6M |
|
97
Thermo Fisher Scientific
TMO
$186B
| $459M | 0.15% | 2,051,723 +233,041 | +13% | +$52.2M |
|
98
Broadcom
AVGO
$1.4T
| $459M | 0.15% | 1,804,947 -296,853 | -14% | -$75.5M |
|
99
Marathon Petroleum
MPC
$54.6B
| $457M | 0.15% | 7,751,675 +339,929 | +5% | +$20.1M |
|
100
Duke Energy
DUK
$95.3B
| $456M | 0.15% | 5,288,921 +483,219 | +10% | +$41.7M |
|